Share on StockTwits

Stereotaxis (NASDAQ:STXS) announced its earnings results on Tuesday. The company reported ($0.19) EPS for the quarter, StockRatingsNetwork reports. The company had revenue of $9.10 million for the quarter, compared to the consensus estimate of $12.20 million.

Shares of Stereotaxis (NASDAQ:STXS) traded down 5.80% on Tuesday, hitting $5.52. 1,049,446 shares of the company’s stock traded hands. Stereotaxis has a 1-year low of $1.104 and a 1-year high of $9.8996. The stock has a 50-day moving average of $5.12 and a 200-day moving average of $3.85. The company’s market cap is $87.7 million.

Stereotaxis, Inc designs, manufactures and markets cardiology instrument control system for use in a hospital’s interventional medical suite, or interventional lab, for the treatment of arrhythmias and coronary artery disease by enabling therapeutic solutions and improving catheter-based, or interventional, procedures.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.